A judge has refused to recuse himself from a stoush between litigation funder Vannin Capital and Clive Palmerâs companies over the appointment of a barrister in a claim springing from the long-running Queensland Nickel liquidation case.
A judge has told mining equipment provider Komatsu to consider whether its sex harassment policies and training are an “adequate” defence to serious allegations of harassment and bullying by a female employee.
The High Court has awarded $27 million in unpaid commissions to a Nigerian entrepreneur tricked into terminating his contract with international bank note manufacturer Securency, reversing a Full Court judgment which slashed his award.
An Australian mother who posted a viral video of her son, who suffers from achondroplasia dwarfism, following a bullying incident has hit the Daily Telegraph’s publisher with a defamation lawsuit over a reporter’s retweet of conspiracy theories that the video was a fake.
A judge has granted a mid-trial bid to bring in “potentially quite significant” new evidence in a class action against Ford over its allegedly defective PowerShift transmissions, finding the failure to file the material earlier was not deliberate but a “mistake” on the part of the lead applicant’s solicitors at Corrs Chambers Westgarth.
After “unavoidable delays”, shareholders will soon be notified of a settlement reached one year ago in a class action against QRxPharma, but a company director has warned group members will receive nothing of consequence and the law firm and funder involved in the case would be disappointed by their takeaways.
Receivers appointed in the wake of the collapse of Banksia Securities may seek costs orders against the estate of deceased funder and class action lawyer Mark Elliott, a court has heard. Meanwhile, the Victorian Bar says it has âevery confidence in the judicial processâ after senior counsel Norman OâBryan yesterday abandoned his defence of misconduct allegations stemming from the case.
AFT Pharmaceuticals has suffered another blow over its Maxigesic advertisements, with a judge finding the marketing material misled consumers by claiming to provide better, faster and more effective pain relief than paracetamol or ibuprofen.
Generic drug maker Sandoz has successfully appealed a $26.3 million judgment finding it infringed a patent owned by rival H Lundbeck relating to the top-selling antidepressant Lexapro.
Fundraising company Appco has reached a settlement to resolve a class action alleging it misclassified its army of sales people as independent contractors.